OPA1 mitochondrial dynamin like GTPase
Last updated 8 May 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The OPA1 gene provides instructions for making a protein that is found in cells and tissues throughout the body. The OPA1 protein is active in the inner membrane of cell structures called mitochondria, which are the energy-producing centers in cells. Mitochondria are dynamic structures that change shape through processes called fission (splitting into smaller pieces) and fusion (combining pieces). Changes in shape are necessary for mitochondrial function and the production of new mitochondria. The OPA1 protein helps to regulate the shape of mitochondria by playing a key role in the fusion process.
Video picks for GenesVideo library
Normal function
The OPA1 gene provides instructions for making a protein that is found in cells and tissues throughout the body. The OPA1 protein is active in the inner membrane of cell structures called mitochondria, which are the energy-producing centers in cells. Mitochondria are dynamic structures that change shape through processes called fission (splitting into smaller pieces) and fusion (combining pieces). Changes in shape are necessary for mitochondrial function and the production of new mitochondria. The OPA1 protein helps to regulate the shape of mitochondria by playing a key role in the fusion process.
The OPA1 protein is also involved in a process that takes place in mitochondria called oxidative phosphorylation, from which cells derive much of their energy. Additionally, the OPA1 protein plays a role in the maintenance of the DNA within mitochondria, called mitochondrial DNA (mtDNA), and in controlled cell death (apoptosis).
Conditions referring to this gene or chromosome
Other names
dynamin-like 120 kDa protein, mitochondrial
FLJ12460
KIAA0567
MGM1
mitochondrial dynamin-like GTPase
NPG
NTG
OPA1_HUMAN
Patient picks for Genes

Men's health
What it's like to have breast cancer when you're a man
While breast cancer is often perceived as a women's disease, men can be diagnosed too. We spoke to Tony Herbert, who was diagnosed with breast cancer in 2011.
by Abi Millar

Treatment and medication
What it's like to be on the organ transplant waiting list
Lisa Ebdon, a recruiter from Warwickshire, does not come across as seriously ill. She goes to work, walks the dog and enjoys running with her daughter Lily. As she explains, it's only when she takes off her glasses that most people realise what she's dealing with. "People are shocked and surprised when they find out that I need a liver transplant. Then I take off my glasses and they see the 'yellows' of my eyes," she says.
by Abi Millar

Cancer
Why are Black men more likely to die from prostate cancer?
Each year, about 52,000 men are diagnosed with prostate cancer in the UK. However, Black men are at higher risk of prostate cancer than other men. 1 in 4 Black men will get prostate cancer in their lifetime. This is double the 1 in 8 risk of other men.
by Emily Jane Bashforth

Cancer
Less survivable cancers are more likely to have late diagnoses
The six less survivable cancers make up around half of all cancer deaths in the UK. However, these cancers are far more likely not to be diagnosed until they have reached later stages. Survival rates could significantly improve if there is more public awareness of symptoms and better diagnostic tools for GPs.
by Amberley Davis

Cancer
What it's like to be a breast surgeon with breast cancer
As a consultant breast surgeon, Dr Liz O'Riordan was used to performing operations, reassuring frightened women and breaking bad news. What she wasn't so familiar with was being the patient herself.
by Natalie Healey

Hormones
What it's like to go through early menopause
The menopause is a natural part of life that occurs when the ovaries stop producing eggs and when a woman's hormone levels change. Although it usually takes place between 45 and 55, around one in 100 women experience the menopause before 40 years of age.
by Lydia Smith
Related patient information and medicines

Patient information leaflet
Muscle weakness
This leaflet looks at types of muscle weakness and discusses the wide range of problems which can cause them. Some of these causes are very common and others are very rare. Examples include: Glycogen storage diseases Blood glucose test (blood sugar) and HbA1c (in which glycogen, a carbohydra... Even rarer, mitochondrial diseases which occur when.

Patient information leaflet
Cyclical vomiting syndrome
Cyclical vomiting syndrome is a condition which occurs mainly in children but can also affect adults. It is more common in people who have migraines. ... The relationship between cyclical vomiting syndrome and migraines is well recognised. Some studies have suggested a link between cyclical vomiting syndrome and autonomic disturbances or.

Patient information leaflet
Can I take Lansoprazole and Rivaroxaban together?
Simply search for your medicines to see potential interactions and w... Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice. Always consult your GP, pharmacist, or another qualified healthcare professional before making decisions about your medications..

Patient information leaflet
Can I take Berberine and Nexplanon together?
Berberine may reduce the effectiveness of the Nexplanon implant, which could increase the risk of an unplanned pregnancy. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.

Patient information leaflet
Can I take Apixaban and Levomepromazine together?
Taking apixaban and levomepromazine together may increase your risk of bleeding. Levomepromazine can sometimes cause a drop in the number ... Simply search for your medicines to see potential interactions and what to do about them. Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute.

Patient information leaflet
Can I take Collagen and Tamoxifen together?
There is no known direct interaction between collagen supplements and tamoxifen. Collagen is a protein found naturally in the body, and taking it as a supplement is generally considered safe alongside this medication. Why this happens Collagen is broken down into amino acids in the digestive tract, similar to eating protein-rich food. It does not.
Further reading and references
- OPA1 mitochondrial dynamin like GTPase; MedlinePlus, National Library of Medicine.
- Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferre M, Guillet V, Gueguen N, Loiseau D, de Crescenzo MA, Verny C, Procaccio V, Lenaers G, Reynier P. OPA1-associated disorders: phenotypes and pathophysiology. Int J Biochem Cell Biol. 2009 Oct;41(10):1855-65. doi: 10.1016/j.biocel.2009.04.012. Epub 2009 Apr 21.
- Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, Campos Y, Rivera H, de la Aleja JG, Carroccia R, Iommarini L, Labauge P, Figarella-Branger D, Marcorelles P, Furby A, Beauvais K, Letournel F, Liguori R, La Morgia C, Montagna P, Liguori M, Zanna C, Rugolo M, Cossarizza A, Wissinger B, Verny C, Schwarzenbacher R, Martin MA, Arenas J, Ayuso C, Garesse R, Lenaers G, Bonneau D, Carelli V. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain. 2008 Feb;131(Pt 2):338-51. doi: 10.1093/brain/awm298. Epub 2007 Dec 24.
- Bonneau D, Colin E, Oca F, Ferre M, Chevrollier A, Gueguen N, Desquiret-Dumas V, N'Guyen S, Barth M, Zanlonghi X, Rio M, Desguerre I, Barnerias C, Momtchilova M, Rodriguez D, Slama A, Lenaers G, Procaccio V, Amati-Bonneau P, Reynier P. Early-onset Behr syndrome due to compound heterozygous mutations in OPA1. Brain. 2014 Oct;137(Pt 10):e301. doi: 10.1093/brain/awu184. Epub 2014 Jul 10. No abstract available.
- Chao de la Barca JM, Prunier-Mirebeau D, Amati-Bonneau P, Ferre M, Sarzi E, Bris C, Leruez S, Chevrollier A, Desquiret-Dumas V, Gueguen N, Verny C, Hamel C, Milea D, Procaccio V, Bonneau D, Lenaers G, Reynier P. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology. Neurobiol Dis. 2016 Jun;90:20-6. doi: 10.1016/j.nbd.2015.08.015. Epub 2015 Aug 23.
- Delettre-Cribaillet C, Hamel CP, Lenaers G. Optic Atrophy Type 1 - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 2007 Jul 13 [updated 2015 Nov 12]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1248/
- Ferre M, Bonneau D, Milea D, Chevrollier A, Verny C, Dollfus H, Ayuso C, Defoort S, Vignal C, Zanlonghi X, Charlin JF, Kaplan J, Odent S, Hamel CP, Procaccio V, Reynier P, Amati-Bonneau P. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat. 2009 Jul;30(7):E692-705. doi: 10.1002/humu.21025.
- Ferre M, Caignard A, Milea D, Leruez S, Cassereau J, Chevrollier A, Amati-Bonneau P, Verny C, Bonneau D, Procaccio V, Reynier P. Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data. Hum Mutat. 2015 Jan;36(1):20-5. doi: 10.1002/humu.22703. Epub 2014 Dec 1.
- Formichi P, Radi E, Giorgi E, Gallus GN, Brunetti J, Battisti C, Rufa A, Dotti MT, Franceschini R, Bracci L, Federico A. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene. J Neurol Sci. 2015 Apr 15;351(1-2):99-108. doi: 10.1016/j.jns.2015.02.047. Epub 2015 Mar 6.
- Schimpf S, Fuhrmann N, Schaich S, Wissinger B. Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons. Hum Mutat. 2008 Jan;29(1):106-12. doi: 10.1002/humu.20607.
- Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L, Lamperti C, Tallaksen CM, Duffey P, Miller J, Whittaker RG, Baker MR, Jackson MJ, Clarke MP, Dhillon B, Czermin B, Stewart JD, Hudson G, Reynier P, Bonneau D, Marques W Jr, Lenaers G, McFarland R, Taylor RW, Turnbull DM, Votruba M, Zeviani M, Carelli V, Bindoff LA, Horvath R, Amati-Bonneau P, Chinnery PF. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010 Mar;133(Pt 3):771-86. doi: 10.1093/brain/awq007. Epub 2010 Feb 15.
- Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, Carelli V. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain. 2008 Feb;131(Pt 2):352-67. doi: 10.1093/brain/awm335.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

